蜜环菌催眠功能优良菌株筛选和发酵工艺优化研究
|
摘要
蜜环菌(Armillaria spp.)属于担子菌门、伞菌目、白蘑科、蜜环菌属。在世界各大洲均有分布，在我国主要分布在黑龙江、吉林、辽宁、内蒙古等省区。蜜环菌是与传统中草药天麻(Gastrodia elata Blume)共生的著名食药兼用的真菌。多年来，经大量的试验研究表明，蜜环菌的菌丝体和发酵液均具有较强的催眠、抗惊厥、抗缺氧等神经调节功能和脑保护功能，还具有增加心、脑血管血流量，增强机体免疫调节功能等生理活性。尤其是在催眠、抗惊厥、抗缺氧和调节心、脑血管功能等方面具有与天麻相同的药理活性。因此，20世纪70年代开始，在对蜜环茵生理活性和化学成分研究，以及蜜环菌的深层发酵工艺和系列制剂的开发等方面引起了中国和世界许多国家的重视，取得了大量研究成果，开发生产出多种蜜环菌制剂。
蜜环菌中含有丰富的化学成分，通过对蜜环菌菌丝体和发酵液的化学成分的系统研究，分离得到了蜜环菌多糖、蜜环菌素等倍半萜类化合物和嘌呤类化合物等多种生理活性物质，并对这些化合物的理化特性和生物学活性进行了较细致的研究。由于野生天麻在我国的资源有限，栽培天麻虽已获得成功，但因受到各种条件影响，其生长周期长，并且必须有蜜环菌作为萌发菌和营养供体，技术要求严格，生产成本高，价格贵，难以满足人们保健和临床用药的需求。以蜜环菌及其发酵产物替代天麻，来解决天麻供应不足，保护野生天麻资源等问题，是一条行之有效的资源开发新途径。多年来，经过科研工作者和医药生产企业的不懈努力，脑心舒口服液、蜜环菌片、蜜环菌糖浆等蜜环菌制剂，在调节睡眠和心、脑血管功能等方面收到了较好疗效。据不完全统计，目前在我国，仅脑心舒口服液的年产值就超过了6亿元以上。但是，脑心舒口服液等蜜环菌制剂的生产，主要以蜜环菌的菌丝体和发酵液为主要原料，没有明确有效部位和活性成分，只能属于三类药物。而且，用于发酵生产的蜜环菌菌种(菌株)还不统一，发酵工艺技术与控制不规范，发酵产物的产量不高，对蜜环菌发酵产物及其制剂的质量监测指标不明确。这些不利因素，影响了蜜环菌及其制剂的生产开发和质量、药效以及产品层次的进一步提高。
本研究是作者主持的吉林省2001年科技发展计划项目“蜜环菌深层发酵工艺及其功能性食品研究”课题的重要组成部分。其主要内容和攻关目标是从长白山野生蜜环菌菌中分离生长性状良好的菌株，通过液体深层发酵特性和动物试验筛选具有催眠功能的优良蜜环菌菌株。在最适的培养基和摇床液体培养条件下扩大培养，将发酵产物利用分离提取等技术手段和动物试验进行有效部位活性跟踪试验，进一步明确蜜环菌发酵产物中催眠功能的有效部位，并以此有效部位的得率为主要指标，进一步优化蜜环菌液体深层发酵的生产工艺，以实现催眠功能提取部位有效得率的最大化。
本研究的试验结果和研究结论包括以下几方面：
1．从长白山不同地区采集到的天麻和蜜环菌的子实体中分离得到了16个蜜环菌菌株，分别为Ar-02，Ar-03，Ar-04，Ar-07，Ar-08，Ar-09，Ar-11，Ar-13，Ar-16，Ar-17，Ar-20，Ar-21，Ar-25，Ar-26，Ar-29，Ar-31。以目前“脑心舒”口服液生产所用的蜜环菌菌株(Ar-00)为对照，通过固体培养和液体培养，开展了各菌株的菌丝和菌索萌发时间及其形态特征、荧光特性、液体培养时菌丝球的形态、大小，发酵液色泽，荧光强度，产物的生物量等方面的试验研究。以各菌株的生长特性和生物量为主要指标，进一步筛选出生长性状良好的8个菌株Ar-02，Ar-03，Ar-07，Ar-08，Ar-09，Ar-11，Ar-13，Ar-31。
2．经液体深层发酵试验研究，确定了8个生长性状良好的蜜环菌菌株各自的最适培养条件，在此基础上，对8个菌株进行了液体扩大培养，以“脑心舒”口服液生产菌株Ar-00为阳性对照菌株，将发酵产物(菌丝体和发酵液)进行催眠功能的动物试验，最终筛选出液体发酵生物量最高，催眠功能明显的优良菌株Ar-07。本研究还对Ar-07菌株进行了分子生物学鉴定，最终将Ar-07菌株确定为奥氏蜜环菌(Armillaria ostoyae Romagn)。通过单因素和正交试验，筛选确定了Ar-07菌株液体深层发酵的最适培养基和摇床扩大培养时的最适初始pH值、装液量、接种方法(菌丝球的破碎均质处理)和接种量、培养温度、摇床转速、乙醇添加量和最佳发酵时间。
3．对Ar-07菌株的液体深层发酵产物(发酵液)进行有效部位的多层次分离、提取，并通过催眠功能的动物试验跟踪，确定了Ar-07菌株发酵液中具有明显催眠功能的有效部位。
4．以发酵液中的催眠功能有效部位得率为主要指标，通过正交试验和发酵动力学研究，进一步优化了蜜环菌液体深层发酵的生产工艺，并与蜜环菌的普通发酵工艺相比较，开展了较大规模的中试研究。发酵产物中的菌丝体产量比普通发酵法提高了18.30％，发酵液中催眠功能有效部位得率比普通发酵法提高了21.64％。通过对中试结果分析检测和动物试验证明，本研究所确定的优化工艺是合理可靠的。
作者首次从野生蜜环菌的采集、菌种分离、催眠活性菌株的优选、有效部位的确定到液体深层发酵工艺的优化，展开了全面、系统的研究工作。本论文具有以下创新点：
1．通过大量的试验研究最终筛选出的蜜环菌Ar-07菌株为生长性状好、生物量高、活性明显、功效稳定的优良菌株，并利用分子生物学鉴定方法将该菌株确定为奥氏蜜环菌(Armillaria ostoyae Romagn)。可为蜜环菌制剂的开发生产提供稳定、可靠的优良菌种。
2．通过对蜜环菌Ar-07菌株液体深层发酵产物的多层次分步提取和催眠功能动物试验跟踪，筛选确定了功能活性明显的有效部位，为蜜环菌深层发酵工艺的进一步优化，发酵产物的质量监控提供了可靠依据，为蜜环菌制剂的二次开发奠定了良好基础。
3．以催眠活性有效部位的得率为主要指标，进一步优化了蜜环菌液体深层发酵的工艺条件和控制参数，并与普通发酵工艺相比较开展了中试生产研究。结果表明，采用优化工艺进行发酵与普通发酵工艺相比，菌丝体的生物量提高了18.30％，发酵液中有效部位的得率提高了21.64％。此项研究成果为今后蜜环菌液体深层发酵生产及其系列制剂的生产开发提供了可靠的工艺技术。
4．本试验确定的破碎匀质接种法经蜜环菌中试生产验证可以提高发酵产物生物量，大量节省菌种的投放量(节省40％)。该法具有明显的创新性，经进一步完善后可以在食药用真菌的液体深层发酵生产中推广应用。
本研究所取得的创新性成果为蜜环菌的发酵特性、发酵产物的化学成分分析和活性单体的提取分离研究以及蜜环菌系列产品的深层次开发利用研究奠定了一定基础，可以为蜜环菌液体深层发酵和系列产品的生产开发提供优良菌株和科学合理的工艺技术，对蜜环菌的标准化发酵生产和工艺质量监控具有良好的指导作用。在提高蜜环菌制剂质量和功效的稳定性，加快“脑心舒”口服液的二次开发和蜜环菌创新性药物的研究以及蜜环菌第三代功能性食品的研究与开发，促进食药用菌的产业化发展等方面具有良好的应用价值和现实意义。
Armillaria spp., belongs to Basidiomycotina, Agaricales, Tricholomataceae, Armillaria. It is distributed all over the continents and mainly in HiLongjiang, JiLin, LiaoNing, NeiMenggu in China. Armillaria spp. is a kind of famous medicinal fungus symbiotic with Chinese herb "Gastrodia elata Blume"(Tianma). Many experiments showed that the mycelia and fermented broth of Armillaria spp. had the function of cerebrum protection and nerve regulation, such as hypnogenesis, anti-convulsion and anti-anoxia. It also has bioactivities such as increasing the blood flow rate in cerebral and cardiovascular vessel and strengthening immune regulation. So great attentions were paid to study bioactivity and chemical components、develope series of preparation of Armillaria spp. and study the submerge fermentation technology since 1970s. And lots of achievements were obtained.
There are abundant chemical components in Armillaria spp. Through the systemic study on the mycelia and fermented broth of Armillaria spp., many chemical compositions have been found, such as polysaccharide, sesquiterpenoids, purine and so on. The physical-chemical properties and bioactivities of those compounds were also studied. As wild TianMa resource is limited in our country. Although it had been cultivated successfully, it still needs Armillaria spp. as germination and nutrition donor. Tianma is hard to satisfy the need of healthcare and clinic use because of its selective techniques, high producing cost and price. It is an effective new way to use Armillaria spp. and its fermented products to replace "TianMa" in order to solve lack-supply and protect wild "TianMa" resource. With years of relentless efforts of scientists and medical enterprises, Armillaria spp. preparations as "NaoXinshu" Oral Liquid, Armillaria spp. pill and Armillaria spp. syrup work a comparatively good cure. Only "NaoXinshu" Oral Liquid one part was earned more than 600millions RMB annually in our country. The Armillaria spp. preparations, taking NaoXinshu Oral Liquid for example, just belongs to the Drug preparationⅢ, because they used Armillaria spp. mycelia and fermented broth as main materials, which did not have clear effective part and active components. What's more, there are still several adverse factors: no unified strains of Armillaria spp. no regulated fermentation technology and control, low effective yield, no clear monitoring aims for products and preparation quality. Not only do all factors above put great impact on the producing, developing and preparation of Armillaria spp., but also restrain products advance.
This paper was the most significant part of "Study on Armillaria spp. submerges fermentation technology and its functional food" which was a science and technology developing plan project of JiLin Province in 2001 conducted by the author. Its chief target was to screen strains with favorable growing characters and soporific function from wild Armillaria spp. in ChangBai Mountain through fermentation and animal trials. The target of this thesis is to clear effective pot with hypnogenesis function, and yield rate of it as chief index, in order to optimize the submerged fermentation technology to realized maximization of the yield rate.
The research results as follows:
1. 16 Armillaria spp. strains were separated from "TianMa" and the mycelia of Armillaria spp. collected from different areas in ChangBai Mountain, which were named Ar-02, Ar-03, Ar-04, Ar-07, Ar-08, Ar-09, Ar-11, Ar-13, Ar-16, Ar-17, Ar-20, Ar-21, Ar-25, Ar-26, Ar-29, Ar-31 after evaluation respectively. Taking the Armillaria spp. strain which was used to produce "NaoXinshu" Oral Liquid (At-00) as a control, many researches has been done to got information about sprouting time of mycelia and rhizomorph, morphological characters, the mycelia shape at liquid culture, the color and luster of the fermented broth, the fluorescence intensity, biomass of the products and so on. These ascertained the growing characters of the strains. And then 8 strains with favorable growing characters (Ar-02, Ar-03, Ar-07, Ar-08, Ar-09, Ar-11, Ar-13, Ar-31) were screened by the indexes, the strains' growing character and biomass.
2. The optimal culture conditions were screened respectively for the 8 Armillaria spp. strains through liquid submerged fermentation study. On the base, the 8 Armillaria spp. strains were cultured enlarging, by using "NaoXinshu" Oral Liquid as a positive control and animal trail for soporific function. Favorable strain Ar-07 with definite soporific function and highest biomass was finally screened. Molecular biological identification was also done, and strain Ar-07 Was confirmed to be Armillaria ostoyae Romagn at last. The optimum culture conditions for Ar-07 was screened and determined through single factor experiment and orthogonal experiment, for example, optimal initial pH value, volume of culture, inoculating method, inoculating volume, cultural temperature, and time.
3. After layers of separating and extracting, the extracting part with definite soporific function in Ar-07 fermented broth was ascertained through animal trials.
4. Armillaria spp. liquid submerged fermentation technology was optimized through orthogonal experiment and kinetics study. The mycelia yield obtained by the optimized technique parameters was higher 18.30％than that of normal fermentation; the yield of soporific function extracting part was higher 21.64％. The optimum technology confirmed by this research was proved reasonable and reliable through analysis test and animal trial.
Since collecting Armillaria spp. samples, separating the strains, screening favorable strains, ascertaining the extracting part and optimizing fermentation technology, the whole course was first systemically studied in this paper. Innovations as follows:
1. Favourable strain Armillaria spp. Ar-07 was finally screened through lots of experiments for its better growing characters, high biomass, definite potency and steady activation. And this strain was confirmed to be Armillmraia ostoyae Romagn by molecular biological identification method. This provided steady and reliable strain for Armillaria spp. preparation production and exploration.
2. The ascertain of Ar-07 extracting part by submerge fermentation and animal trials, provided reference to optimize fermentation technology and monitor the quality for fermented products, and laid foundation for the secondary exploration of Armillaria spp. preparations.
3. The culture conditions and control parameter were optimized and expanding trials were done. The yield rate of mycelia raised 18.3％and the valid yield rate of the extracting part with soporific function in broth increased 21.64％. So reliable technology was prepared for the development of Armillaria spp. liquid submerged fermentation.
4. The smashing and homogenizing inoculation method confirmed. It has proved that could raise the biomass and save the inoculation amount (save 40％). Obviously, this method is innovative. It can be practiced in the fungus liquid submerged fermentation after further perfecting.
The innovative achievement obtained in this paper prepared the ground for the further study in Armillaria spp. fermented characters, chemical components analysis of fermented products, separating and extracting the effective part and active monomer and Armillaria spp. products applying. The research also provided scientific and proper technology and favorable Armillaria spp. strain for developing series of products. There was certain reference value to Armillaria spp. standard fermentation producing and technique monitoring. The results had great applying value and immediate significance in increasing the quality and stability of Armillaria spp. preparation. It could enhance the second development of"NaoXinshu" Oral Liquid and development of the Third Generation Functional Food, and improve the industrial secondary exploration of edible and pharmaceutical mushroom.
蜜环菌中含有丰富的化学成分，通过对蜜环菌菌丝体和发酵液的化学成分的系统研究，分离得到了蜜环菌多糖、蜜环菌素等倍半萜类化合物和嘌呤类化合物等多种生理活性物质，并对这些化合物的理化特性和生物学活性进行了较细致的研究。由于野生天麻在我国的资源有限，栽培天麻虽已获得成功，但因受到各种条件影响，其生长周期长，并且必须有蜜环菌作为萌发菌和营养供体，技术要求严格，生产成本高，价格贵，难以满足人们保健和临床用药的需求。以蜜环菌及其发酵产物替代天麻，来解决天麻供应不足，保护野生天麻资源等问题，是一条行之有效的资源开发新途径。多年来，经过科研工作者和医药生产企业的不懈努力，脑心舒口服液、蜜环菌片、蜜环菌糖浆等蜜环菌制剂，在调节睡眠和心、脑血管功能等方面收到了较好疗效。据不完全统计，目前在我国，仅脑心舒口服液的年产值就超过了6亿元以上。但是，脑心舒口服液等蜜环菌制剂的生产，主要以蜜环菌的菌丝体和发酵液为主要原料，没有明确有效部位和活性成分，只能属于三类药物。而且，用于发酵生产的蜜环菌菌种(菌株)还不统一，发酵工艺技术与控制不规范，发酵产物的产量不高，对蜜环菌发酵产物及其制剂的质量监测指标不明确。这些不利因素，影响了蜜环菌及其制剂的生产开发和质量、药效以及产品层次的进一步提高。
本研究是作者主持的吉林省2001年科技发展计划项目“蜜环菌深层发酵工艺及其功能性食品研究”课题的重要组成部分。其主要内容和攻关目标是从长白山野生蜜环菌菌中分离生长性状良好的菌株，通过液体深层发酵特性和动物试验筛选具有催眠功能的优良蜜环菌菌株。在最适的培养基和摇床液体培养条件下扩大培养，将发酵产物利用分离提取等技术手段和动物试验进行有效部位活性跟踪试验，进一步明确蜜环菌发酵产物中催眠功能的有效部位，并以此有效部位的得率为主要指标，进一步优化蜜环菌液体深层发酵的生产工艺，以实现催眠功能提取部位有效得率的最大化。
本研究的试验结果和研究结论包括以下几方面：
1．从长白山不同地区采集到的天麻和蜜环菌的子实体中分离得到了16个蜜环菌菌株，分别为Ar-02，Ar-03，Ar-04，Ar-07，Ar-08，Ar-09，Ar-11，Ar-13，Ar-16，Ar-17，Ar-20，Ar-21，Ar-25，Ar-26，Ar-29，Ar-31。以目前“脑心舒”口服液生产所用的蜜环菌菌株(Ar-00)为对照，通过固体培养和液体培养，开展了各菌株的菌丝和菌索萌发时间及其形态特征、荧光特性、液体培养时菌丝球的形态、大小，发酵液色泽，荧光强度，产物的生物量等方面的试验研究。以各菌株的生长特性和生物量为主要指标，进一步筛选出生长性状良好的8个菌株Ar-02，Ar-03，Ar-07，Ar-08，Ar-09，Ar-11，Ar-13，Ar-31。
2．经液体深层发酵试验研究，确定了8个生长性状良好的蜜环菌菌株各自的最适培养条件，在此基础上，对8个菌株进行了液体扩大培养，以“脑心舒”口服液生产菌株Ar-00为阳性对照菌株，将发酵产物(菌丝体和发酵液)进行催眠功能的动物试验，最终筛选出液体发酵生物量最高，催眠功能明显的优良菌株Ar-07。本研究还对Ar-07菌株进行了分子生物学鉴定，最终将Ar-07菌株确定为奥氏蜜环菌(Armillaria ostoyae Romagn)。通过单因素和正交试验，筛选确定了Ar-07菌株液体深层发酵的最适培养基和摇床扩大培养时的最适初始pH值、装液量、接种方法(菌丝球的破碎均质处理)和接种量、培养温度、摇床转速、乙醇添加量和最佳发酵时间。
3．对Ar-07菌株的液体深层发酵产物(发酵液)进行有效部位的多层次分离、提取，并通过催眠功能的动物试验跟踪，确定了Ar-07菌株发酵液中具有明显催眠功能的有效部位。
4．以发酵液中的催眠功能有效部位得率为主要指标，通过正交试验和发酵动力学研究，进一步优化了蜜环菌液体深层发酵的生产工艺，并与蜜环菌的普通发酵工艺相比较，开展了较大规模的中试研究。发酵产物中的菌丝体产量比普通发酵法提高了18.30％，发酵液中催眠功能有效部位得率比普通发酵法提高了21.64％。通过对中试结果分析检测和动物试验证明，本研究所确定的优化工艺是合理可靠的。
作者首次从野生蜜环菌的采集、菌种分离、催眠活性菌株的优选、有效部位的确定到液体深层发酵工艺的优化，展开了全面、系统的研究工作。本论文具有以下创新点：
1．通过大量的试验研究最终筛选出的蜜环菌Ar-07菌株为生长性状好、生物量高、活性明显、功效稳定的优良菌株，并利用分子生物学鉴定方法将该菌株确定为奥氏蜜环菌(Armillaria ostoyae Romagn)。可为蜜环菌制剂的开发生产提供稳定、可靠的优良菌种。
2．通过对蜜环菌Ar-07菌株液体深层发酵产物的多层次分步提取和催眠功能动物试验跟踪，筛选确定了功能活性明显的有效部位，为蜜环菌深层发酵工艺的进一步优化，发酵产物的质量监控提供了可靠依据，为蜜环菌制剂的二次开发奠定了良好基础。
3．以催眠活性有效部位的得率为主要指标，进一步优化了蜜环菌液体深层发酵的工艺条件和控制参数，并与普通发酵工艺相比较开展了中试生产研究。结果表明，采用优化工艺进行发酵与普通发酵工艺相比，菌丝体的生物量提高了18.30％，发酵液中有效部位的得率提高了21.64％。此项研究成果为今后蜜环菌液体深层发酵生产及其系列制剂的生产开发提供了可靠的工艺技术。
4．本试验确定的破碎匀质接种法经蜜环菌中试生产验证可以提高发酵产物生物量，大量节省菌种的投放量(节省40％)。该法具有明显的创新性，经进一步完善后可以在食药用真菌的液体深层发酵生产中推广应用。
本研究所取得的创新性成果为蜜环菌的发酵特性、发酵产物的化学成分分析和活性单体的提取分离研究以及蜜环菌系列产品的深层次开发利用研究奠定了一定基础，可以为蜜环菌液体深层发酵和系列产品的生产开发提供优良菌株和科学合理的工艺技术，对蜜环菌的标准化发酵生产和工艺质量监控具有良好的指导作用。在提高蜜环菌制剂质量和功效的稳定性，加快“脑心舒”口服液的二次开发和蜜环菌创新性药物的研究以及蜜环菌第三代功能性食品的研究与开发，促进食药用菌的产业化发展等方面具有良好的应用价值和现实意义。
Armillaria spp., belongs to Basidiomycotina, Agaricales, Tricholomataceae, Armillaria. It is distributed all over the continents and mainly in HiLongjiang, JiLin, LiaoNing, NeiMenggu in China. Armillaria spp. is a kind of famous medicinal fungus symbiotic with Chinese herb "Gastrodia elata Blume"(Tianma). Many experiments showed that the mycelia and fermented broth of Armillaria spp. had the function of cerebrum protection and nerve regulation, such as hypnogenesis, anti-convulsion and anti-anoxia. It also has bioactivities such as increasing the blood flow rate in cerebral and cardiovascular vessel and strengthening immune regulation. So great attentions were paid to study bioactivity and chemical components、develope series of preparation of Armillaria spp. and study the submerge fermentation technology since 1970s. And lots of achievements were obtained.
There are abundant chemical components in Armillaria spp. Through the systemic study on the mycelia and fermented broth of Armillaria spp., many chemical compositions have been found, such as polysaccharide, sesquiterpenoids, purine and so on. The physical-chemical properties and bioactivities of those compounds were also studied. As wild TianMa resource is limited in our country. Although it had been cultivated successfully, it still needs Armillaria spp. as germination and nutrition donor. Tianma is hard to satisfy the need of healthcare and clinic use because of its selective techniques, high producing cost and price. It is an effective new way to use Armillaria spp. and its fermented products to replace "TianMa" in order to solve lack-supply and protect wild "TianMa" resource. With years of relentless efforts of scientists and medical enterprises, Armillaria spp. preparations as "NaoXinshu" Oral Liquid, Armillaria spp. pill and Armillaria spp. syrup work a comparatively good cure. Only "NaoXinshu" Oral Liquid one part was earned more than 600millions RMB annually in our country. The Armillaria spp. preparations, taking NaoXinshu Oral Liquid for example, just belongs to the Drug preparationⅢ, because they used Armillaria spp. mycelia and fermented broth as main materials, which did not have clear effective part and active components. What's more, there are still several adverse factors: no unified strains of Armillaria spp. no regulated fermentation technology and control, low effective yield, no clear monitoring aims for products and preparation quality. Not only do all factors above put great impact on the producing, developing and preparation of Armillaria spp., but also restrain products advance.
This paper was the most significant part of "Study on Armillaria spp. submerges fermentation technology and its functional food" which was a science and technology developing plan project of JiLin Province in 2001 conducted by the author. Its chief target was to screen strains with favorable growing characters and soporific function from wild Armillaria spp. in ChangBai Mountain through fermentation and animal trials. The target of this thesis is to clear effective pot with hypnogenesis function, and yield rate of it as chief index, in order to optimize the submerged fermentation technology to realized maximization of the yield rate.
The research results as follows:
1. 16 Armillaria spp. strains were separated from "TianMa" and the mycelia of Armillaria spp. collected from different areas in ChangBai Mountain, which were named Ar-02, Ar-03, Ar-04, Ar-07, Ar-08, Ar-09, Ar-11, Ar-13, Ar-16, Ar-17, Ar-20, Ar-21, Ar-25, Ar-26, Ar-29, Ar-31 after evaluation respectively. Taking the Armillaria spp. strain which was used to produce "NaoXinshu" Oral Liquid (At-00) as a control, many researches has been done to got information about sprouting time of mycelia and rhizomorph, morphological characters, the mycelia shape at liquid culture, the color and luster of the fermented broth, the fluorescence intensity, biomass of the products and so on. These ascertained the growing characters of the strains. And then 8 strains with favorable growing characters (Ar-02, Ar-03, Ar-07, Ar-08, Ar-09, Ar-11, Ar-13, Ar-31) were screened by the indexes, the strains' growing character and biomass.
2. The optimal culture conditions were screened respectively for the 8 Armillaria spp. strains through liquid submerged fermentation study. On the base, the 8 Armillaria spp. strains were cultured enlarging, by using "NaoXinshu" Oral Liquid as a positive control and animal trail for soporific function. Favorable strain Ar-07 with definite soporific function and highest biomass was finally screened. Molecular biological identification was also done, and strain Ar-07 Was confirmed to be Armillaria ostoyae Romagn at last. The optimum culture conditions for Ar-07 was screened and determined through single factor experiment and orthogonal experiment, for example, optimal initial pH value, volume of culture, inoculating method, inoculating volume, cultural temperature, and time.
3. After layers of separating and extracting, the extracting part with definite soporific function in Ar-07 fermented broth was ascertained through animal trials.
4. Armillaria spp. liquid submerged fermentation technology was optimized through orthogonal experiment and kinetics study. The mycelia yield obtained by the optimized technique parameters was higher 18.30％than that of normal fermentation; the yield of soporific function extracting part was higher 21.64％. The optimum technology confirmed by this research was proved reasonable and reliable through analysis test and animal trial.
Since collecting Armillaria spp. samples, separating the strains, screening favorable strains, ascertaining the extracting part and optimizing fermentation technology, the whole course was first systemically studied in this paper. Innovations as follows:
1. Favourable strain Armillaria spp. Ar-07 was finally screened through lots of experiments for its better growing characters, high biomass, definite potency and steady activation. And this strain was confirmed to be Armillmraia ostoyae Romagn by molecular biological identification method. This provided steady and reliable strain for Armillaria spp. preparation production and exploration.
2. The ascertain of Ar-07 extracting part by submerge fermentation and animal trials, provided reference to optimize fermentation technology and monitor the quality for fermented products, and laid foundation for the secondary exploration of Armillaria spp. preparations.
3. The culture conditions and control parameter were optimized and expanding trials were done. The yield rate of mycelia raised 18.3％and the valid yield rate of the extracting part with soporific function in broth increased 21.64％. So reliable technology was prepared for the development of Armillaria spp. liquid submerged fermentation.
4. The smashing and homogenizing inoculation method confirmed. It has proved that could raise the biomass and save the inoculation amount (save 40％). Obviously, this method is innovative. It can be practiced in the fungus liquid submerged fermentation after further perfecting.
The innovative achievement obtained in this paper prepared the ground for the further study in Armillaria spp. fermented characters, chemical components analysis of fermented products, separating and extracting the effective part and active monomer and Armillaria spp. products applying. The research also provided scientific and proper technology and favorable Armillaria spp. strain for developing series of products. There was certain reference value to Armillaria spp. standard fermentation producing and technique monitoring. The results had great applying value and immediate significance in increasing the quality and stability of Armillaria spp. preparation. It could enhance the second development of"NaoXinshu" Oral Liquid and development of the Third Generation Functional Food, and improve the industrial secondary exploration of edible and pharmaceutical mushroom.
引文
[1]王秋颖，郭顺星．天麻人工栽培技术[M]．北京：中国农业出版社，2001，34～36
[2]Korhonen K. Interfertility and clonal size in the Armillariella mellea complex[J], karstenia, 1978, 18:31～42
[3]Anderson J B, Ullrich H C. Biological species of Armillaria mellea in North America[J]. Mycologia,1979, 71:402～404
[4]Morrison D J, Chu D, Johnson ASL. Species of Armillaria in British Columbia[J]. Canadian Journal of Plant Pathology, 1985, 7:242～246
[5]Kile G A, Watling R. Identification& occurrence of Australian Armillaria species, including A. pallidula sp. nov. and comparative studies between them and non-Australian tropical and Indian Armillaria[J]. Transacton of the British Mycological Society. 1988, 91: 305～315
[6]Volk T J, Burdsall H H. A nomenclatural study of Armillaria & Armillariella Species[M]. Synopsis Fungorum 8, Fungiflora-Oslo-Norway, 1995
[7]Cha J Y, Sung J M, Igarashi T. Biological species and morphological characteristics of Armillaria mellea complex in Hokkaido: A. sinapina and two new species, A. jazoensis & A. singula[J]. Mycoscience, 1994, 35:39
[8]Mohammed C, Guillaumin J J, Berthelays. Preliminary investigation about the taxonomy and genetics of African Armillaria species[C]. Proceedings of the Seventh International Conference on Root and Butt Rots Vernon&Victoria, British Columbia, Canada. August 9-16, 1988, Edited by Morrison, D. J. International Union of Forestry Research Organisations (IUFRO) working party S2.06.01,447～457
[9]Pegler D N. A preliminary Agaric flora of east Africa[J]. Her majesty's stationery office, London. 1977, 92～95
[10]戴芳澜．中国真菌总汇[M]．北京：科学出版社，1979，378～379
[11]贺伟，秦国夫，沈瑞祥．大兴安岭和长白山地区蜜环菌生物种的研究[J]．真菌学报，1996，15(1)：9～16
[12]秦国夫，赵俊，戴玉成等．中国东北蜜环菌根朽病病原菌的鉴定[J]．Fungi Science，1999，14(1，2)：53～62
[13]李玉，图力古尔．中国长白山蘑菇[M]．北京：中国科学技术出版社，2003，10
[14]Alexopoulos著，李玉等译．菌物学概论[M]．第四版，466
[15]中国医学科学院药物研究所编著．中草药现代研究(第一卷)[M]．北京：北京医科大学、中国协和医科大学联合出版社，1995，5
[16]李景惠．天麻蜜环菌的特征与特性[J]．特种经济动植物，2002(11)：25
[17]Singh P, Bal A K. Ultrastructure of the fructification of Armillaria mellea[C]. 2nd international congress of plant pathology, Minneapolis, 1973
[18]Guillaumin J J. Contribution al etude des Armillaires phytopathogens, en particulier du groupe Mellea: cycle caryologique, notion despece, role biologique des especes[dissertation]. University Claude Bernard-Laon Ⅰ, 1986, 270
[19]ShawⅢ C G, Kile G A. Armillaria root disease[M]. Agriculture Handbook No.691, 1991, 233
[20]Fox R T V. Armillaria root rot: biology and control of honey fungus[M], Andover: Intercept, 2000,222
[21]Tang H, Raabe R D. Sporphore production and heterothallism in Clitocybe tabescens[J]. Phytopathology, 1973 (63): 1218.
[22]Kile G A. Armillaria luteobubalina: a primary cause of decline and death of trees in mixed species eucalypt forests in central Victoria[J]. Australian Forest Research, 1981 (11): 63～77
[23]Grillo R, Korhonen K, Hantula J, et al. Genetic evidence for somatic haploidization in developing fruit bodies of Armillaria tabescens[J], Fungal Genetics and biology, 2000, 30:135～145
[24]Rykowski K. Obserwacje nad owocowaniem opienki miedowej Armillaria mellea(Vahl)Karst. W czystych kulturach[C].[Observations on the frutification of the honey fungus Armillaria mellea(Vahl)Karst. In pure cultures.](in Polish). Prate Intytutu Badawczego Lesnictwa. 1974, 431: 146～167
[25]庄严，赵俊，秦国夫等．奥氏蜜环菌杂交双倍体子实体的人工诱导[J]．中国森林病虫，2003，22(5)：13～16
[26]薛梅，王秋颖，樊锦燕．蜜环菌子实体发生条件的初探[J]．食品工业科技，2004，10：58～60
[27]秦国夫，赵俊等．蜜环菌的生物学研究进展[J]．东北林业大学学报，2004，11(6)：89～94
[28]Schmid R, Liese W. Feinstruktur der rhizomorphen von Armillaria mellea[J].Phytopathologische Zeitschrift. 1970, 68:221～231
[29]Motta J J. Cytology and morphologenesis in the rhizomorph of Armillaria mellea[J]. American Journal of Botany, 1969, 56:610～619
[30]Motta J J. Rhizomorph cytology and morphologenesis in the Armillaria tabescens[J]. Mycologia. 1982, 74:671～674
[31]Motta J J. Histochemistry of the rhizomoroh meristem of Armillaria mellea[J]. American Journal of Botany, 1971, 58:80～87
[32]Power K A, Rayner A D. Occurrence bundles of microfilaments in circum-medullary cells underlying
第六章 结论
结论
参考文献 #73
致谢 #83
[49]刘成运，张新生，徐维明．天麻消化蜜环菌过程中超微结构的变化及酸性磷酸酶细胞化学定位[J]．植物学报，1983，25：301～306
[50]张维经．天麻与其真菌营养[J]．西北植物学报，1987，7：215～221
[51]周弦．食菌植物天麻栽培探索[J]．中草药通讯，1973，(1)：77～80
[52]周弦，杨兴华，梁汉兴等．天麻形态学[M]．北京：科学出版社，1987，76～93
[53]徐锦堂，牟春．天麻原球茎生长发育与紫萁小菇及蜜环菌的关系[J]．植物学报，1990，32：26～31
[54]Burgeff H. Mycorrhiza of orchids. In: Withn er C L ed., The Orchids: A scientific Survey. New York: Ronald, 1959, 361～395
[55]Campbell E O. The mycorrhiza of Gastrodia cunninghamii HF[J]. Trans Roy Soc New Zealand, 1964, 1: 289～296
[56]Campbell E O. The fungal association in a colony of Gastrodia sesamoides R. Br[J]. Trans Roy Soc New Zealand, 1964, 2:237～246
[57]Harley J L, Smith S E. Mycorrhizal Symbiosis[M]. London: Academic Press, 1983, 268～295
[58]陈正中．天麻与蜜环菌的共生匹配过程[J]．食用菌，1997，19(5)：10
[59]张维经，李碧峰．天麻与蜜环菌的关系[J]．植物学报，1980(1)：57～61
[60]蔡义荣．浅论天麻和蜜环菌及其共生关系[J]．生物学通报，1987(1)：11～12
[61]王贺，王震宇，张福锁等．天麻吸收蜜环菌营养机制的细胞学研究[J]．植物学报，1997(6)：500～504
[62]庄毅．天麻和蜜环菌[J]．食用菌，1983(6)：47～48
[63]华秀爱．速培蜜环菌促进天麻速生高产试验[J]．中国食用菌，2004，23(1)：27～29
[64]孙士青，陈贯虹．不同蜜环菌对天麻生物产量及天麻素含量的影响[J]．山东科学，2003，16(2)：7～10
[65]陈明义，李福后，边银丙．蜜环菌不同菌株对天麻产量的影响[J]．食用菌学报，2004，11(1)：46～48
[66]梅全善，毕焕新主编．现代中药药理手册[M]．北京：中国中医药出版社，1998，10
[67]沈映君．中药药理学[M]．北京：人民卫生出版社，2000，10：797
[68]黄正良．我国天麻的药理研究及临床应用现状[J]．中西医结合杂志，1985(4)：251～254
[69]高南南，于澍任，徐锦堂．天麻对老龄大鼠学习记忆的改善作用[J]．中国中药杂志，1995，20(9)：562～563，568
[70]陆光伟．天麻及其活性成分研究[J]．中草药，1985，16(9)：40～41
[71]邝安堃，吴云瑞等．豚鼠实验性癫痫病的研究—治疗癫痫发作及防止剪毛暴殄现象方法的探讨[J]．中华医学杂志，1958，44：582
[72]江振裕，张德星．天麻和香荚兰素抗痫作用的研究[J]．生理学报，1961，24：187
[73]沈道修，张效文．天麻的抗惊与镇痛作用的研究[J]．药学学报，1963，10(4)：242
[74]杨世林，兰进，徐锦堂．天麻的研究进展[J]．中草药，2000，31(1)：66～69
[75]朱荃．天麻多糖免疫活性的初步观察[J]．中成药研究，1984，12：25～26
[76]于龙顺，赵国举，任世兰等．天麻抗炎效应的研究[J]．中草药，1989，20(5)：19～21
[77]林树钱编．中国药用菌生产与产品开发[M]．中国农业出版社，．2000，11
[78]徐锦堂，郭顺星．猪苓与蜜环菌的关系[J]．真菌学报，1992，11(2)：142～145
[79]王秋颖，徐锦堂．蜜环菌发酵液在猪苓菌发酵过程中的应用[J]．中国药学杂志，1993，28(8)：466～467
[80]夏洪燕，郭顺星．猪苓菌丝细胞活性氧的产生及其种类[J]．菌物系统，2000，19(4)：576～579
[81]Guo S X, Wang Q Y, Zhuang J H, Xing X K. Discovery and application of the companion fungus related to Sclerotial formation from hyphae of Grifola umbellate[J]. Acta Botanica, 2002, 44:1151～1154
[82]刑晓科，郭顺星．猪苓、伴生菌及蜜环菌共培养的形态学研究[J]．菌物系统，2003，22(4)：653～660
[83]Garraway M.O, Hutterman A, Phillip M W. Ontogeny and Physiology. In: Shaw Ⅲ, Kile G A, ed. Armillaria root rot[M]. Agriculture Handbook, 1991, 691:21～47
[84]Garrett S D. Rhizomorph behaviour in Armillaria mellea (Vahl) Quel Ⅰ: Factors controlling rhizomorph initiation by Armillaria mellea in pure culture[J]. Annals of Botany(London), 1953, 17:63～79
[85]郭顺星，徐锦堂，肖培根等．蜜环菌的化学成分及应用研究[J]．微生物学通报，1996(4)：239～240
[86]陈小梅，郭顺星，王秋颖．蜜环菌不同发育阶段多糖成分的研究[J]．中国中药杂志，2001(6)：381～383
[87]洪毅，沈业寿，樊叶杨．蜜环菌菌索多糖的分离纯化及其部分理化性质[J]．中国药学杂志，1998(9)：526～528
[88]孔小卫，沈业寿等．蜜环菌多糖Ar-Ⅰ的部分理化性质及结构研究[J]．食品科学，2003，24(7)：23～26
[89]李立恒，王征，谢达平．蜜环菌深层发酵液多糖的分离纯化和组成[J]．湖南农业大学学报(自然科学版)，2004，30(3)：275～277
[90]于敏，沈业寿．野生和人工培养蜜环菌菌索多糖含量及免疫活性的比较[J]．安徽大学学报(自然科学版)，2002，26(1)：107～110
[91]张庆林，张慧娟，王秉及．蜜环菌多糖的分离纯化及组成分析[J]．中国药学杂志，1995，30(7)：401～402
[92]谭周进，谢达平，王征等．蜜环菌多糖分离纯化及性质的研究[J]．食品科学，2002，23(9)：49～52
[93]Yang Junshan, Chen Yuwu, Feng Xiaozhang et al. Chemical Constituents of Armillaria mellea mycelium (Ⅰ)Isolation and Characterization of Armillarin and Armillaridin[J]. Planta Medica, 1984(50):288～290
[94]J.S.Yang, Y.W.Chen, X.Z.Feng et al. Isolation and Structure Elucidation of Armillaricin[J]. Planta Medica, 1989(55):564～565
[95]J.S.Yang, Y. L.Su, Y.L.Wang et al. Isolation and Structures of Two New Sesquiterpenoid Aromatic Esters: Armillarigin and Armillarikin[J]. Planta Medica, 1989(55):479～481
[96]杨峻山，苏亚伦，王玉兰等．蜜环菌菌丝体化学成分的研究(Ⅴ)[J]．药学学报，1990(1)：24～28
[97]杨峻山，苏亚伦，王玉兰等．蜜环菌菌丝体化学成分的研究(Ⅵ)[J]．药学学报，1990(5)：353～356
[98]杨峻山，苏亚伦，王玉兰等．蜜环菌菌丝体化学成分的研究(Ⅶ)[J]．药学学报，1991(2)：117～122
[99]J.S.Yang. Chinese Chemical Letters, 1990, 1(2): 173～174
[100]Tadashi Obuchi, Hideaki Kondoh, Naoharu Watanabe et al. Armillaric Acid, A New Antibiotic Produced by Armillaria mellea[J]. Planta Medica, 1990(56): 198～201
[101]J.S.Yang, Y. L.Su, Y.L.Wang et al. Two Novel Protoilludance Norsesquiterpene Esters, Armillasin and Armillatin from Armillaria mellea[J]. Planta Medica, 1991 (57): 478～480
[102]Dervilla M.X. Donnelly, Fumiko Abe, Donal.J.Coveney et al. Antibacterial Sesquiterpene Arylesters from Armillaria mellea[J]. Journal.of Natural Products, 1985, 48(1): 10～16
[103]Dervilla M.X. Donnelly, Paul.F.Quigley, Donal.J.Coveney et al. Two New Sesquiterpene Esters from Armillaria mellea[J]. Phytochemistry, 1987, 26(11): 3075～3077
[104]Dervilla M.X. Donnelly, Donal.J.Coveney, Naomichi Fukuda. New Sesquiterpene Aryl Esters from Armillaria mellea[J]. J.of Natural Products, 1986, 49(1): 111～116
[105]Dervilla M.X. Donnelly, Phona M.Hutchinson. Armillane, a Saturated Sesquiterpene Ester from Armillaria mellea[J]. Phytochemistry, 1990, 29(1): 179～182
[106]Donnelly D M X. Sesquiterpenearylesters from Armillaria tabescens[J].Phytochemistry, 1997, 44: 1473～1478
[107]Cremin P. A liquid chromatography-thermospray ionization-mass spectrometry guided isolation of a new sesquiterpene arylesters from Armillaria novae-zelandiae[J]. Chem Soc., Perkin Trans 1, 2000(1):2325～2329
[108]赵爱华，魏均娴．倍半萜类化合物生理活性研究进展[J]．天然产物研究与开发，1995(4)：65～70
[109]Naoharu Watanabe, Tadashi Obuchi, Masaharu Tamai et al. A Novel N~6-Substituted Acenosine Isolated from Armillaria mellea as a Cerebral-Protecting Compound[J]. Planta Medica, 1990 (56):48～52
[110]徐锦堂．中国药用真菌学[M]．北京：北京医科大学、中国协和医科大学联合出版社，1997：235～236
[111]杨峻山，冯孝章，岳德超等．新抗菌素蜜环菌酸的制取方法．中国专利公开号：1034956
[112]Tadashi Obuchi, Hideaki Kondoh, Naohary Watanebe etc. Armillaramide, a new sphingolipid from the fungus Amrillaria mellea[J]. Fitoterapia, 2001, 72 (8): 858～864
[113]Healy.V, Doonan.S, et al. Purification, characterization and cDNA cloning of an endo-exonuclease from the basidiomycete fungus Armillaria mellea[J]. Biochem Journal, 1999, 339 (5): 713～720
[114]Healy.V, O'Connell J, et al. The lysine-specific proteinase from Armillaria mellea is a member of a novel class of metalloendopeptidases located in Basidiomycetes[J]. Biochemical and Biophysical Research Communications, 1999, 262 (1): 60～63
[115]王秋颖，郭顺星，樊锦艳等．不同蜜环菌菌株酯酶同工酶及过氧化物同工酶的研究[J]．食品工业科技，2002(2)：38～40
[116]肖亚中，王军，王怡平等．蜜环菌胞外漆酶的合成、纯化及性质研究[J]．生物工程学报，2002，18(4)：457～462
[117]Youn H D, Hah Y C, Kang S O. Role of laccase in lignin degradation by white-rot fungi[J]. FEMS Microbiol, 1995, 132:183～188
[118]Bourbonnais R, Paice M G. Oxidation of non-phenolic subatrates an expanded role of for laccase in biodegradation[J]. FEMS Lett, 1990, 267:99～102
[119]Bourbonnais R, Paice M G. Enzymatic delignification of kraft pulp using laccase and a mediator[J]. TAPPI.J. 1996, 79:199～204
[120]Ullah M A, Bedford C T, Evana C S. Reaction of pentachlorphenol with laccase from Coriolus Versicolor[J].Appl Microbiol Biotech-nol, 2001, 55:317～320
[121]Abadulla E, Tzanov T, Costa S et al. Decolorization and detoxification of textile dyes with a laccase from Trametes hursuta[J]. Appl Environ Microbiol, 2000, 66 (8):3357～3362
[122]Ullah M A, Kadhim H, Rastall R A et al. Evaluation of solid substrates for enzyme production by Coriolus vercolor, for use in biore medafion on chlorophenols in aqueous effluents[J]. Appl Microbiol Biotechnol. 2000, 54:832～837
[123]Schneider P. Caspersen M P, Mondorf K et al. Characterization of a Coprinus cinereus laccase[J]. Enzyme Microbiol Technol, 1999, 25:502～508
[124]Robene-Soustrade I, Lung-Escarmant B. Laeease isoenzyme patterns of European Armillaria species from culture filtrates and infected woody plant tissues[J]. European Journal of Forest Pathology, 1997, 27(2): 105～114
[125]Rehman A U, Thurston C F. Purification of laccase Ⅰ from Armillria mellea[J]. Journal of General Microbiology, 1992, 138:1251～1257
[126]石磊，曹瑞敏，卢士香等．榛蘑中一种新化合物的提取、分离及鉴定[J]．白求恩医科大学学报，1998．24(4)：343
[127]张嘉，杨延旗，淡海等．蜜环菌的化学成分[J]．西北植物学报，2002，22(4)：952～956
[128]中国医学科学院药物研究所药理室新药组．天麻水剂及蜜环菌发酵液对神经系统的药理作用[J]．中华医学杂志，1997(8)：470～472
[129]郑建仙主编．功能性食品(第二卷)[M]．北京：中国轻工业出版社．1999．9
[130]于敏，沈业寿，梅一德．蜜环菌菌索多糖的免疫增强功能的研究『J]．生物学杂志，2001(4)：16～18
[131]林志彬，章达敏，夏冬．蜜环菌多糖对小鼠免疫功能的影响[J]．中国药理学通报，1988，4(2)：93～96
[132]张颖，沈业寿，葛继志等．蜜环菌多糖对低能离子束诱变作用的恢复效应[J]．激光生物学报，2002，11(4)：272～275
[133]于敏，沈业寿．蜜环菌菌索多糖对小鼠血糖及急性毒性作用研究[J]．中国食用菌，2001，21(1)：35～37
[134]凌关庭主编．保健食品原料手册[M]．北京：化学工业出版社精细化工出版中心，2002．2
[135]Yamamoto K, Mina T, Uen R, and hayaiahi O. Muramgy dipeptide elicited production of PGD_2 form astrocytes in culture[J]. Biochem Biophys. Res. Commum, 1988, 156:882～888
[136]Lieberman H, Waldhausser F, Carfield G. Effects of melatotion huama mood and pripromance[J]. Brain Res, 1984, 323:201～207
[137]S．F．Pang．褪黑素及其受体的研究现状与展望[J]．第二军医大学学报，2001，22(1)：5～7
[138]Hughes R J, Sack R L, lewy A J. The role of melationin and circadian phase in agerelated sleep maintenance insomnia: assessment in a clinical trial of melation in replacement[J]. Sleep, 1998, 21(1):52
[139]Youngsted S D, Kripke O, Elliot A. Melationin excretin is not related to sleep in the elderly[J]. J Pineal Res., 1998, 24(2): 142
[140]刘长云，王海明，陈坚等．一氧化氮对睡眠-觉醒周期的调控[J]．中国行为医学科学，2001，10(4)：392～393
[141]Thannickal T C, Moore R Y, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy[J]. Neuron, 2000, 27:469～474
[142]Nishino S, Ripley B, Overeem S, et al. Hypocretin(orexin) deficiency in human narcolepsy[J]. Lancet, 2000, 355:39～40
[143]何文波，彭克美，邱德新．神经肽Orexins的研究进展[J]．华中农业大学学报，2004，23(6)：692～697
[144]Hagan J J, Leslie R A, Patel S, et al. OrexinA activates locus coeruleus cell firing and increases arousal in the rat[J]. Proc Natl Acad Sci USA, 1999, 96(19): 10911～10916
[145]Taheri S, Sunter D, Dakin C, et al. Diurnal variation in orexinA immunoreactivity and prepro-orexin mRNA in the rat central nervous system[J]. Neurosci Lett, 2000,279(2): 109～112
[146]Fujiki N, Yoshida Y, Ripley B, et al. Changes in CSF hypocretinl(orexinA) levels in rats across 24 hours and in response to food deprivation[J]. Neuroreport, 2001, 12(5): 993～997
[147]Yoshida Y, Fujiki N, Nakajima T, et al. Fluctuation of extracellular hypocretinl(orexinA) levels in the rat in relation to the light-dark cycle and sleep-wake activities[J]. Eur J Neurosci, 2001, 14(7): 1075～1081
[148]Kummer M, Neidert S J, Johren O, et al. Orexin(hypocretin) gene expression in rat ependymal cells[J]. Neuroreport, 2001, 12(10): 2117～2120
[149]张家俊，陈文为．中药酸枣仁、龙齿、石菖蒲对小鼠脑组织单胺类神经递质及其代谢物的影响[J]．北京中医药大学学报，1995，18(6)：64
[150]丘明明，黎有新．酸枣仁研究近况[J]．中医药研究，1995，(4)：60
[151]朱国庆，王敏，翟进等，酸枣仁有效成分对小鼠多导睡眠描记的影响[J]．安徽医科大学学报，1991．26(3)：165
[152]郭胜民，范晓雯，宋少刚等．酸枣仁总皂甙中枢抑制作用的研究[J]．西北药学杂志，1996，11(4)：166
[153]Watanabd I, Saito H, Takagi K. Pharmacological studies of Zizyphus seeds[J]. Japan J Pharmalol, 1973, 23 (4): 563
[154]吴寿金，赵泰，秦永祺．现代中药成分化学[M]．北京：中国医药科技出版社，2002：482
[155]赵求贤，王清莲，黄建华．酸枣仁油对小鼠中枢神经系统的影响[J]．西安医科大学学报，1995，16(4)：432
[156]Woo WS, Kang SS, Wagnet H, et al.Acylated Flavone-C-Glycosides from the seeds of Zizyphus Jujuba[J]. Phytochemistry, 1980, 19, 2791
[157]史琪荣，周耘，周萍等．中药酸枣仁的研究概况[J]．药学实践杂志，2004，22(2)：94～98
[158]张均田．神经药理学研究进展[M]．北京：人民卫生出版社，2002：38
[159]Hansson G. Setfert G. Production of zone lines(Pseudosclerotia) in veneers[J]. Material and Organism, 1987. 22:87～10
[160]Morrison D J. Ion uptake by rhyzomorphs of Armillaria mellea[J]. Canadian Journal of Botany, 1975, 53:48～51
[161]王楚桃，白先权，朱利泉等．~(60)Co-γ射线辐照对蜜环菌生长及酶活性的影响[J]．西南农业大学学报，1998，20(1)：19～23
[162]杨云鹏，岳德超，霍泽民．蜜环菌的深层培养[J]．微生物学报，1976，16(3)：206～213
[163]张颖，沈业寿．液体发酵蜜环菌培养条件的优化及菌体多糖的分离[J]．食用菌，2001(2)：5～7
[164]王怡平，戴玲，沈业寿．蜜环菌多糖的生物合成与发酵条件的相关性[J]．生物学杂志，2000，17(2)：13～14
[165]邵伟，乐超银，刘世玲等．蜜环菌深层发酵条件研究[J]．中国食用菌，2004，23(3)：50～51
[166]李立恒，王征，谢达平．蜜环菌深层发酵产多糖的研究[J]．湖南农业大学学报(自然科学版)，2003．29(5)：428～430
[167]谭周进，谢达平等．蜜环菌胞外多糖的发酵条件研究[J]．微生物学通报，2002，29(3)：33～37
[168]谭周进，谢达平，王征．蜜环菌多糖生产培养基的研究[J]．食品与机械，2001(5)：18～19，21
[169]李玉，王琦．药用菌物学[M]．长春：吉林科学技术出版社，1996：221～233
[170]刘景圣，孟宪军．功能性食品[M]．北京：中国农业出版社，2005：2，97
[2]Korhonen K. Interfertility and clonal size in the Armillariella mellea complex[J], karstenia, 1978, 18:31～42
[3]Anderson J B, Ullrich H C. Biological species of Armillaria mellea in North America[J]. Mycologia,1979, 71:402～404
[4]Morrison D J, Chu D, Johnson ASL. Species of Armillaria in British Columbia[J]. Canadian Journal of Plant Pathology, 1985, 7:242～246
[5]Kile G A, Watling R. Identification& occurrence of Australian Armillaria species, including A. pallidula sp. nov. and comparative studies between them and non-Australian tropical and Indian Armillaria[J]. Transacton of the British Mycological Society. 1988, 91: 305～315
[6]Volk T J, Burdsall H H. A nomenclatural study of Armillaria & Armillariella Species[M]. Synopsis Fungorum 8, Fungiflora-Oslo-Norway, 1995
[7]Cha J Y, Sung J M, Igarashi T. Biological species and morphological characteristics of Armillaria mellea complex in Hokkaido: A. sinapina and two new species, A. jazoensis & A. singula[J]. Mycoscience, 1994, 35:39
[8]Mohammed C, Guillaumin J J, Berthelays. Preliminary investigation about the taxonomy and genetics of African Armillaria species[C]. Proceedings of the Seventh International Conference on Root and Butt Rots Vernon&Victoria, British Columbia, Canada. August 9-16, 1988, Edited by Morrison, D. J. International Union of Forestry Research Organisations (IUFRO) working party S2.06.01,447～457
[9]Pegler D N. A preliminary Agaric flora of east Africa[J]. Her majesty's stationery office, London. 1977, 92～95
[10]戴芳澜．中国真菌总汇[M]．北京：科学出版社，1979，378～379
[11]贺伟，秦国夫，沈瑞祥．大兴安岭和长白山地区蜜环菌生物种的研究[J]．真菌学报，1996，15(1)：9～16
[12]秦国夫，赵俊，戴玉成等．中国东北蜜环菌根朽病病原菌的鉴定[J]．Fungi Science，1999，14(1，2)：53～62
[13]李玉，图力古尔．中国长白山蘑菇[M]．北京：中国科学技术出版社，2003，10
[14]Alexopoulos著，李玉等译．菌物学概论[M]．第四版，466
[15]中国医学科学院药物研究所编著．中草药现代研究(第一卷)[M]．北京：北京医科大学、中国协和医科大学联合出版社，1995，5
[16]李景惠．天麻蜜环菌的特征与特性[J]．特种经济动植物，2002(11)：25
[17]Singh P, Bal A K. Ultrastructure of the fructification of Armillaria mellea[C]. 2nd international congress of plant pathology, Minneapolis, 1973
[18]Guillaumin J J. Contribution al etude des Armillaires phytopathogens, en particulier du groupe Mellea: cycle caryologique, notion despece, role biologique des especes[dissertation]. University Claude Bernard-Laon Ⅰ, 1986, 270
[19]ShawⅢ C G, Kile G A. Armillaria root disease[M]. Agriculture Handbook No.691, 1991, 233
[20]Fox R T V. Armillaria root rot: biology and control of honey fungus[M], Andover: Intercept, 2000,222
[21]Tang H, Raabe R D. Sporphore production and heterothallism in Clitocybe tabescens[J]. Phytopathology, 1973 (63): 1218.
[22]Kile G A. Armillaria luteobubalina: a primary cause of decline and death of trees in mixed species eucalypt forests in central Victoria[J]. Australian Forest Research, 1981 (11): 63～77
[23]Grillo R, Korhonen K, Hantula J, et al. Genetic evidence for somatic haploidization in developing fruit bodies of Armillaria tabescens[J], Fungal Genetics and biology, 2000, 30:135～145
[24]Rykowski K. Obserwacje nad owocowaniem opienki miedowej Armillaria mellea(Vahl)Karst. W czystych kulturach[C].[Observations on the frutification of the honey fungus Armillaria mellea(Vahl)Karst. In pure cultures.](in Polish). Prate Intytutu Badawczego Lesnictwa. 1974, 431: 146～167
[25]庄严，赵俊，秦国夫等．奥氏蜜环菌杂交双倍体子实体的人工诱导[J]．中国森林病虫，2003，22(5)：13～16
[26]薛梅，王秋颖，樊锦燕．蜜环菌子实体发生条件的初探[J]．食品工业科技，2004，10：58～60
[27]秦国夫，赵俊等．蜜环菌的生物学研究进展[J]．东北林业大学学报，2004，11(6)：89～94
[28]Schmid R, Liese W. Feinstruktur der rhizomorphen von Armillaria mellea[J].Phytopathologische Zeitschrift. 1970, 68:221～231
[29]Motta J J. Cytology and morphologenesis in the rhizomorph of Armillaria mellea[J]. American Journal of Botany, 1969, 56:610～619
[30]Motta J J. Rhizomorph cytology and morphologenesis in the Armillaria tabescens[J]. Mycologia. 1982, 74:671～674
[31]Motta J J. Histochemistry of the rhizomoroh meristem of Armillaria mellea[J]. American Journal of Botany, 1971, 58:80～87
[32]Power K A, Rayner A D. Occurrence bundles of microfilaments in circum-medullary cells underlying
第六章 结论
结论
参考文献 #73
致谢 #83
[49]刘成运，张新生，徐维明．天麻消化蜜环菌过程中超微结构的变化及酸性磷酸酶细胞化学定位[J]．植物学报，1983，25：301～306
[50]张维经．天麻与其真菌营养[J]．西北植物学报，1987，7：215～221
[51]周弦．食菌植物天麻栽培探索[J]．中草药通讯，1973，(1)：77～80
[52]周弦，杨兴华，梁汉兴等．天麻形态学[M]．北京：科学出版社，1987，76～93
[53]徐锦堂，牟春．天麻原球茎生长发育与紫萁小菇及蜜环菌的关系[J]．植物学报，1990，32：26～31
[54]Burgeff H. Mycorrhiza of orchids. In: Withn er C L ed., The Orchids: A scientific Survey. New York: Ronald, 1959, 361～395
[55]Campbell E O. The mycorrhiza of Gastrodia cunninghamii HF[J]. Trans Roy Soc New Zealand, 1964, 1: 289～296
[56]Campbell E O. The fungal association in a colony of Gastrodia sesamoides R. Br[J]. Trans Roy Soc New Zealand, 1964, 2:237～246
[57]Harley J L, Smith S E. Mycorrhizal Symbiosis[M]. London: Academic Press, 1983, 268～295
[58]陈正中．天麻与蜜环菌的共生匹配过程[J]．食用菌，1997，19(5)：10
[59]张维经，李碧峰．天麻与蜜环菌的关系[J]．植物学报，1980(1)：57～61
[60]蔡义荣．浅论天麻和蜜环菌及其共生关系[J]．生物学通报，1987(1)：11～12
[61]王贺，王震宇，张福锁等．天麻吸收蜜环菌营养机制的细胞学研究[J]．植物学报，1997(6)：500～504
[62]庄毅．天麻和蜜环菌[J]．食用菌，1983(6)：47～48
[63]华秀爱．速培蜜环菌促进天麻速生高产试验[J]．中国食用菌，2004，23(1)：27～29
[64]孙士青，陈贯虹．不同蜜环菌对天麻生物产量及天麻素含量的影响[J]．山东科学，2003，16(2)：7～10
[65]陈明义，李福后，边银丙．蜜环菌不同菌株对天麻产量的影响[J]．食用菌学报，2004，11(1)：46～48
[66]梅全善，毕焕新主编．现代中药药理手册[M]．北京：中国中医药出版社，1998，10
[67]沈映君．中药药理学[M]．北京：人民卫生出版社，2000，10：797
[68]黄正良．我国天麻的药理研究及临床应用现状[J]．中西医结合杂志，1985(4)：251～254
[69]高南南，于澍任，徐锦堂．天麻对老龄大鼠学习记忆的改善作用[J]．中国中药杂志，1995，20(9)：562～563，568
[70]陆光伟．天麻及其活性成分研究[J]．中草药，1985，16(9)：40～41
[71]邝安堃，吴云瑞等．豚鼠实验性癫痫病的研究—治疗癫痫发作及防止剪毛暴殄现象方法的探讨[J]．中华医学杂志，1958，44：582
[72]江振裕，张德星．天麻和香荚兰素抗痫作用的研究[J]．生理学报，1961，24：187
[73]沈道修，张效文．天麻的抗惊与镇痛作用的研究[J]．药学学报，1963，10(4)：242
[74]杨世林，兰进，徐锦堂．天麻的研究进展[J]．中草药，2000，31(1)：66～69
[75]朱荃．天麻多糖免疫活性的初步观察[J]．中成药研究，1984，12：25～26
[76]于龙顺，赵国举，任世兰等．天麻抗炎效应的研究[J]．中草药，1989，20(5)：19～21
[77]林树钱编．中国药用菌生产与产品开发[M]．中国农业出版社，．2000，11
[78]徐锦堂，郭顺星．猪苓与蜜环菌的关系[J]．真菌学报，1992，11(2)：142～145
[79]王秋颖，徐锦堂．蜜环菌发酵液在猪苓菌发酵过程中的应用[J]．中国药学杂志，1993，28(8)：466～467
[80]夏洪燕，郭顺星．猪苓菌丝细胞活性氧的产生及其种类[J]．菌物系统，2000，19(4)：576～579
[81]Guo S X, Wang Q Y, Zhuang J H, Xing X K. Discovery and application of the companion fungus related to Sclerotial formation from hyphae of Grifola umbellate[J]. Acta Botanica, 2002, 44:1151～1154
[82]刑晓科，郭顺星．猪苓、伴生菌及蜜环菌共培养的形态学研究[J]．菌物系统，2003，22(4)：653～660
[83]Garraway M.O, Hutterman A, Phillip M W. Ontogeny and Physiology. In: Shaw Ⅲ, Kile G A, ed. Armillaria root rot[M]. Agriculture Handbook, 1991, 691:21～47
[84]Garrett S D. Rhizomorph behaviour in Armillaria mellea (Vahl) Quel Ⅰ: Factors controlling rhizomorph initiation by Armillaria mellea in pure culture[J]. Annals of Botany(London), 1953, 17:63～79
[85]郭顺星，徐锦堂，肖培根等．蜜环菌的化学成分及应用研究[J]．微生物学通报，1996(4)：239～240
[86]陈小梅，郭顺星，王秋颖．蜜环菌不同发育阶段多糖成分的研究[J]．中国中药杂志，2001(6)：381～383
[87]洪毅，沈业寿，樊叶杨．蜜环菌菌索多糖的分离纯化及其部分理化性质[J]．中国药学杂志，1998(9)：526～528
[88]孔小卫，沈业寿等．蜜环菌多糖Ar-Ⅰ的部分理化性质及结构研究[J]．食品科学，2003，24(7)：23～26
[89]李立恒，王征，谢达平．蜜环菌深层发酵液多糖的分离纯化和组成[J]．湖南农业大学学报(自然科学版)，2004，30(3)：275～277
[90]于敏，沈业寿．野生和人工培养蜜环菌菌索多糖含量及免疫活性的比较[J]．安徽大学学报(自然科学版)，2002，26(1)：107～110
[91]张庆林，张慧娟，王秉及．蜜环菌多糖的分离纯化及组成分析[J]．中国药学杂志，1995，30(7)：401～402
[92]谭周进，谢达平，王征等．蜜环菌多糖分离纯化及性质的研究[J]．食品科学，2002，23(9)：49～52
[93]Yang Junshan, Chen Yuwu, Feng Xiaozhang et al. Chemical Constituents of Armillaria mellea mycelium (Ⅰ)Isolation and Characterization of Armillarin and Armillaridin[J]. Planta Medica, 1984(50):288～290
[94]J.S.Yang, Y.W.Chen, X.Z.Feng et al. Isolation and Structure Elucidation of Armillaricin[J]. Planta Medica, 1989(55):564～565
[95]J.S.Yang, Y. L.Su, Y.L.Wang et al. Isolation and Structures of Two New Sesquiterpenoid Aromatic Esters: Armillarigin and Armillarikin[J]. Planta Medica, 1989(55):479～481
[96]杨峻山，苏亚伦，王玉兰等．蜜环菌菌丝体化学成分的研究(Ⅴ)[J]．药学学报，1990(1)：24～28
[97]杨峻山，苏亚伦，王玉兰等．蜜环菌菌丝体化学成分的研究(Ⅵ)[J]．药学学报，1990(5)：353～356
[98]杨峻山，苏亚伦，王玉兰等．蜜环菌菌丝体化学成分的研究(Ⅶ)[J]．药学学报，1991(2)：117～122
[99]J.S.Yang. Chinese Chemical Letters, 1990, 1(2): 173～174
[100]Tadashi Obuchi, Hideaki Kondoh, Naoharu Watanabe et al. Armillaric Acid, A New Antibiotic Produced by Armillaria mellea[J]. Planta Medica, 1990(56): 198～201
[101]J.S.Yang, Y. L.Su, Y.L.Wang et al. Two Novel Protoilludance Norsesquiterpene Esters, Armillasin and Armillatin from Armillaria mellea[J]. Planta Medica, 1991 (57): 478～480
[102]Dervilla M.X. Donnelly, Fumiko Abe, Donal.J.Coveney et al. Antibacterial Sesquiterpene Arylesters from Armillaria mellea[J]. Journal.of Natural Products, 1985, 48(1): 10～16
[103]Dervilla M.X. Donnelly, Paul.F.Quigley, Donal.J.Coveney et al. Two New Sesquiterpene Esters from Armillaria mellea[J]. Phytochemistry, 1987, 26(11): 3075～3077
[104]Dervilla M.X. Donnelly, Donal.J.Coveney, Naomichi Fukuda. New Sesquiterpene Aryl Esters from Armillaria mellea[J]. J.of Natural Products, 1986, 49(1): 111～116
[105]Dervilla M.X. Donnelly, Phona M.Hutchinson. Armillane, a Saturated Sesquiterpene Ester from Armillaria mellea[J]. Phytochemistry, 1990, 29(1): 179～182
[106]Donnelly D M X. Sesquiterpenearylesters from Armillaria tabescens[J].Phytochemistry, 1997, 44: 1473～1478
[107]Cremin P. A liquid chromatography-thermospray ionization-mass spectrometry guided isolation of a new sesquiterpene arylesters from Armillaria novae-zelandiae[J]. Chem Soc., Perkin Trans 1, 2000(1):2325～2329
[108]赵爱华，魏均娴．倍半萜类化合物生理活性研究进展[J]．天然产物研究与开发，1995(4)：65～70
[109]Naoharu Watanabe, Tadashi Obuchi, Masaharu Tamai et al. A Novel N~6-Substituted Acenosine Isolated from Armillaria mellea as a Cerebral-Protecting Compound[J]. Planta Medica, 1990 (56):48～52
[110]徐锦堂．中国药用真菌学[M]．北京：北京医科大学、中国协和医科大学联合出版社，1997：235～236
[111]杨峻山，冯孝章，岳德超等．新抗菌素蜜环菌酸的制取方法．中国专利公开号：1034956
[112]Tadashi Obuchi, Hideaki Kondoh, Naohary Watanebe etc. Armillaramide, a new sphingolipid from the fungus Amrillaria mellea[J]. Fitoterapia, 2001, 72 (8): 858～864
[113]Healy.V, Doonan.S, et al. Purification, characterization and cDNA cloning of an endo-exonuclease from the basidiomycete fungus Armillaria mellea[J]. Biochem Journal, 1999, 339 (5): 713～720
[114]Healy.V, O'Connell J, et al. The lysine-specific proteinase from Armillaria mellea is a member of a novel class of metalloendopeptidases located in Basidiomycetes[J]. Biochemical and Biophysical Research Communications, 1999, 262 (1): 60～63
[115]王秋颖，郭顺星，樊锦艳等．不同蜜环菌菌株酯酶同工酶及过氧化物同工酶的研究[J]．食品工业科技，2002(2)：38～40
[116]肖亚中，王军，王怡平等．蜜环菌胞外漆酶的合成、纯化及性质研究[J]．生物工程学报，2002，18(4)：457～462
[117]Youn H D, Hah Y C, Kang S O. Role of laccase in lignin degradation by white-rot fungi[J]. FEMS Microbiol, 1995, 132:183～188
[118]Bourbonnais R, Paice M G. Oxidation of non-phenolic subatrates an expanded role of for laccase in biodegradation[J]. FEMS Lett, 1990, 267:99～102
[119]Bourbonnais R, Paice M G. Enzymatic delignification of kraft pulp using laccase and a mediator[J]. TAPPI.J. 1996, 79:199～204
[120]Ullah M A, Bedford C T, Evana C S. Reaction of pentachlorphenol with laccase from Coriolus Versicolor[J].Appl Microbiol Biotech-nol, 2001, 55:317～320
[121]Abadulla E, Tzanov T, Costa S et al. Decolorization and detoxification of textile dyes with a laccase from Trametes hursuta[J]. Appl Environ Microbiol, 2000, 66 (8):3357～3362
[122]Ullah M A, Kadhim H, Rastall R A et al. Evaluation of solid substrates for enzyme production by Coriolus vercolor, for use in biore medafion on chlorophenols in aqueous effluents[J]. Appl Microbiol Biotechnol. 2000, 54:832～837
[123]Schneider P. Caspersen M P, Mondorf K et al. Characterization of a Coprinus cinereus laccase[J]. Enzyme Microbiol Technol, 1999, 25:502～508
[124]Robene-Soustrade I, Lung-Escarmant B. Laeease isoenzyme patterns of European Armillaria species from culture filtrates and infected woody plant tissues[J]. European Journal of Forest Pathology, 1997, 27(2): 105～114
[125]Rehman A U, Thurston C F. Purification of laccase Ⅰ from Armillria mellea[J]. Journal of General Microbiology, 1992, 138:1251～1257
[126]石磊，曹瑞敏，卢士香等．榛蘑中一种新化合物的提取、分离及鉴定[J]．白求恩医科大学学报，1998．24(4)：343
[127]张嘉，杨延旗，淡海等．蜜环菌的化学成分[J]．西北植物学报，2002，22(4)：952～956
[128]中国医学科学院药物研究所药理室新药组．天麻水剂及蜜环菌发酵液对神经系统的药理作用[J]．中华医学杂志，1997(8)：470～472
[129]郑建仙主编．功能性食品(第二卷)[M]．北京：中国轻工业出版社．1999．9
[130]于敏，沈业寿，梅一德．蜜环菌菌索多糖的免疫增强功能的研究『J]．生物学杂志，2001(4)：16～18
[131]林志彬，章达敏，夏冬．蜜环菌多糖对小鼠免疫功能的影响[J]．中国药理学通报，1988，4(2)：93～96
[132]张颖，沈业寿，葛继志等．蜜环菌多糖对低能离子束诱变作用的恢复效应[J]．激光生物学报，2002，11(4)：272～275
[133]于敏，沈业寿．蜜环菌菌索多糖对小鼠血糖及急性毒性作用研究[J]．中国食用菌，2001，21(1)：35～37
[134]凌关庭主编．保健食品原料手册[M]．北京：化学工业出版社精细化工出版中心，2002．2
[135]Yamamoto K, Mina T, Uen R, and hayaiahi O. Muramgy dipeptide elicited production of PGD_2 form astrocytes in culture[J]. Biochem Biophys. Res. Commum, 1988, 156:882～888
[136]Lieberman H, Waldhausser F, Carfield G. Effects of melatotion huama mood and pripromance[J]. Brain Res, 1984, 323:201～207
[137]S．F．Pang．褪黑素及其受体的研究现状与展望[J]．第二军医大学学报，2001，22(1)：5～7
[138]Hughes R J, Sack R L, lewy A J. The role of melationin and circadian phase in agerelated sleep maintenance insomnia: assessment in a clinical trial of melation in replacement[J]. Sleep, 1998, 21(1):52
[139]Youngsted S D, Kripke O, Elliot A. Melationin excretin is not related to sleep in the elderly[J]. J Pineal Res., 1998, 24(2): 142
[140]刘长云，王海明，陈坚等．一氧化氮对睡眠-觉醒周期的调控[J]．中国行为医学科学，2001，10(4)：392～393
[141]Thannickal T C, Moore R Y, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy[J]. Neuron, 2000, 27:469～474
[142]Nishino S, Ripley B, Overeem S, et al. Hypocretin(orexin) deficiency in human narcolepsy[J]. Lancet, 2000, 355:39～40
[143]何文波，彭克美，邱德新．神经肽Orexins的研究进展[J]．华中农业大学学报，2004，23(6)：692～697
[144]Hagan J J, Leslie R A, Patel S, et al. OrexinA activates locus coeruleus cell firing and increases arousal in the rat[J]. Proc Natl Acad Sci USA, 1999, 96(19): 10911～10916
[145]Taheri S, Sunter D, Dakin C, et al. Diurnal variation in orexinA immunoreactivity and prepro-orexin mRNA in the rat central nervous system[J]. Neurosci Lett, 2000,279(2): 109～112
[146]Fujiki N, Yoshida Y, Ripley B, et al. Changes in CSF hypocretinl(orexinA) levels in rats across 24 hours and in response to food deprivation[J]. Neuroreport, 2001, 12(5): 993～997
[147]Yoshida Y, Fujiki N, Nakajima T, et al. Fluctuation of extracellular hypocretinl(orexinA) levels in the rat in relation to the light-dark cycle and sleep-wake activities[J]. Eur J Neurosci, 2001, 14(7): 1075～1081
[148]Kummer M, Neidert S J, Johren O, et al. Orexin(hypocretin) gene expression in rat ependymal cells[J]. Neuroreport, 2001, 12(10): 2117～2120
[149]张家俊，陈文为．中药酸枣仁、龙齿、石菖蒲对小鼠脑组织单胺类神经递质及其代谢物的影响[J]．北京中医药大学学报，1995，18(6)：64
[150]丘明明，黎有新．酸枣仁研究近况[J]．中医药研究，1995，(4)：60
[151]朱国庆，王敏，翟进等，酸枣仁有效成分对小鼠多导睡眠描记的影响[J]．安徽医科大学学报，1991．26(3)：165
[152]郭胜民，范晓雯，宋少刚等．酸枣仁总皂甙中枢抑制作用的研究[J]．西北药学杂志，1996，11(4)：166
[153]Watanabd I, Saito H, Takagi K. Pharmacological studies of Zizyphus seeds[J]. Japan J Pharmalol, 1973, 23 (4): 563
[154]吴寿金，赵泰，秦永祺．现代中药成分化学[M]．北京：中国医药科技出版社，2002：482
[155]赵求贤，王清莲，黄建华．酸枣仁油对小鼠中枢神经系统的影响[J]．西安医科大学学报，1995，16(4)：432
[156]Woo WS, Kang SS, Wagnet H, et al.Acylated Flavone-C-Glycosides from the seeds of Zizyphus Jujuba[J]. Phytochemistry, 1980, 19, 2791
[157]史琪荣，周耘，周萍等．中药酸枣仁的研究概况[J]．药学实践杂志，2004，22(2)：94～98
[158]张均田．神经药理学研究进展[M]．北京：人民卫生出版社，2002：38
[159]Hansson G. Setfert G. Production of zone lines(Pseudosclerotia) in veneers[J]. Material and Organism, 1987. 22:87～10
[160]Morrison D J. Ion uptake by rhyzomorphs of Armillaria mellea[J]. Canadian Journal of Botany, 1975, 53:48～51
[161]王楚桃，白先权，朱利泉等．~(60)Co-γ射线辐照对蜜环菌生长及酶活性的影响[J]．西南农业大学学报，1998，20(1)：19～23
[162]杨云鹏，岳德超，霍泽民．蜜环菌的深层培养[J]．微生物学报，1976，16(3)：206～213
[163]张颖，沈业寿．液体发酵蜜环菌培养条件的优化及菌体多糖的分离[J]．食用菌，2001(2)：5～7
[164]王怡平，戴玲，沈业寿．蜜环菌多糖的生物合成与发酵条件的相关性[J]．生物学杂志，2000，17(2)：13～14
[165]邵伟，乐超银，刘世玲等．蜜环菌深层发酵条件研究[J]．中国食用菌，2004，23(3)：50～51
[166]李立恒，王征，谢达平．蜜环菌深层发酵产多糖的研究[J]．湖南农业大学学报(自然科学版)，2003．29(5)：428～430
[167]谭周进，谢达平等．蜜环菌胞外多糖的发酵条件研究[J]．微生物学通报，2002，29(3)：33～37
[168]谭周进，谢达平，王征．蜜环菌多糖生产培养基的研究[J]．食品与机械，2001(5)：18～19，21
[169]李玉，王琦．药用菌物学[M]．长春：吉林科学技术出版社，1996：221～233
[170]刘景圣，孟宪军．功能性食品[M]．北京：中国农业出版社，2005：2，97